cerrar
Tagged with Opinion,

COVID-19: A Material Disruptor
Regular PharmaBoardroom contributor David Crean looks at how the ongoing global coronavirus outbreak has impacted the global economy, how the…

USMCA Sets a New Standard for International Trade
Jonathan Kimball of the Association for Accessible Medicines (AAM) in the USA outlines why the signing of the US-Mexico-Canada Agreement (USMCA) in…

Politics & Markets: The Role of the Private Sector in…
Brendan Shaw outlines the long road still to travel to meet the UN Sustainable Development goal of ensuring basic healthcare financing for every…

Coronavirus Poised to Undermine China’s Healthcare Miracle
Eurasia Group's Aditya Bhattacharji examines the unfolding coronavirus outbreak, the prospects for China's political and economic stability, and how…

Bringing Patient Experience to Regulatory Decision-Making:…
Takeda's Jessica S. Scott examines the steps already being taken to bring greater patient engagement to drug development and the regulatory…

Opportunities to Fix Medicare Part D
The Association for Accessible Medicines' Chip Davis outlines the ways in which the US Medicare programme needs updating in order to promote generic…

Creating a Data-Driven Research Ecosystem with Patients at the…
Health Catalyst’s Elia Stupka explains why and how patients must be kept at the centre of the healthcare systems of the future, even as they become…

A More Measured Tone at J.P. Morgan Healthcare Conference 2020
David Crean summarises the mood at the recent J.P. Morgan Healthcare Conference 2020 in San Francisco, noting a more subdued atmosphere than previous…

Global Pharma has Reinvented R&D: Will Canadian Start-Ups…
John L. Wallace of Antibe Therapeutics highlights how Canadian innovation stands to put the country at the forefront of the next wave of global…

Biosimilar Uptake in Europe: Big Challenges; Bigger Rewards
Isabell Remus, chair of the Biosimilar Medicines Group at Medicines for Europe outlines the issues that need to be addressed to keep driving…

The Fight Against Superbugs: Properly Incentivising Antimicrobial…
BIO's Greg Frank outlines the alarming growth of drug-resistant infections and the steps that need to be taken to combat this rapidly emerging global…

The US in 2020: Structural Constraints to Rein in Political…
Eurasia Group’s Aditya Bhattacharji examines the stalling of healthcare reforms in the US and what changes to US healthcare it is realistic to…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here